The focus of this grant is on the role of one particular transcription factor, SCIP/tst-1/Oct-6, in the development of oligodendrocytes. The logic of studying transcription factors in the process of differentiation is clear; differentiation requires changes in the expression of many genes, transcription factor regulate gene expression, so that transcription factors regulate differentiation. The central hypothesis is that SCIP/tst- 1/Oct-6 plays an important role in the regulation of early oligodendrocyte development. Such a role is in keeping with the known roles of the prototypes of POU family of transcription factors, Pit-1, Oct, and Unc, which regulate the differentiation of several cell types. I have shown that SCIP/tst-1/Oct-6 is transiently expressed in oligodendrocytes, at an early state when they have differentiated from neural-glial stem cells, but have not acquired the phenotype of immature oligodendrocytes. Whether SCIP?tst-1/Oct-6 is necessary and sufficient of oligodendrocyte differentiation will be tested directly by examining oligodendrocyte development in SCIP/tst-1/Oct-6""""""""knock-out"""""""" mice, and by over-expressing SCIP/tst-1/Oct-6 in neural-glial stem cells with an adenovirus vector, respectively. This work is directly relevant to diseases that affect myelin, the most common of which is multiple sclerosis (MS). Oligodendrocytes are the only myelinating cells of the CNS, and the recovery from an attack of MS is probably limited, at least in part, by the limited amount of remyelination that occurs. It is unclear why remyelination is limited, aas large numbers of immature oligodendrocytes are found in fresh lesion in the brains of MS patients. Thus, if we understood the regulation of oligodendrocyte development, then we would potentially be able to improve remyelination in experimental models of remyelination, and finally in patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29NS034528-03
Application #
2431288
Study Section
Neurology C Study Section (NEUC)
Program Officer
Kerza-Kwiatecki, a P
Project Start
1995-07-15
Project End
2000-05-31
Budget Start
1997-06-01
Budget End
1998-05-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Neurology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Arroyo, Edgardo J; Sirkowski, Erich E; Chitale, Rohan et al. (2004) Acute demyelination disrupts the molecular organization of peripheral nervous system nodes. J Comp Neurol 479:424-34
Scherer, Steven S; Arroyo, Edgardo J (2002) Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 7:1-12
Awatramani, Rajeshwar; Shumas, Susan; Kamholz, John et al. (2002) TGFbeta1 modulates the phenotype of Schwann cells at the transcriptional level. Mol Cell Neurosci 19:307-19
Arroyo, Edgardo J; Xu, Theodore; Grinspan, Judith et al. (2002) Genetic dysmyelination alters the molecular architecture of the nodal region. J Neurosci 22:1726-37
Scherer, S S; Xu, T; Crino, P et al. (2001) Ezrin, radixin, and moesin are components of Schwann cell microvilli. J Neurosci Res 65:150-64
Arroyo, E J; Xu, T; Poliak, S et al. (2001) Internodal specializations of myelinated axons in the central nervous system. Cell Tissue Res 305:53-66
Sperber, B R; Boyle-Walsh, E A; Engleka, M J et al. (2001) A unique role for Fyn in CNS myelination. J Neurosci 21:2039-47
Arroyo, E J; Scherer, S S (2000) On the molecular architecture of myelinated fibers. Histochem Cell Biol 113:18-Jan
Arroyo, E J; Xu, Y T; Zhou, L et al. (1999) Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. J Neurocytol 28:333-47
Scherer, S S (1999) Nodes, paranodes, and incisures: from form to function. Ann N Y Acad Sci 883:131-42

Showing the most recent 10 out of 14 publications